Form 4 for RLGT RADIANT LOGISTICS, INC
Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-26 · accession 0001209191-22-039861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-29 | 2022-06-26 | RLGT | CRAIN BOHN H | CEO, Dir, 10% | M - OptEx | $2.45 | +63.3K | 1.12M | +6% | +$155.1K |
| DM | 2022-06-29 | 2022-06-26 | RLGT | CRAIN BOHN H | CEO, Dir, 10% | F - Tax | $7.76 | -30.5K | 1.10M | -3% | -$237.0K |
| DM | 2022-06-29 | 2022-06-26 | RLGT | CRAIN BOHN H | CEO, Dir, 10% | M - OptEx | $2.45 | -63.3K | 0 | -100% | -$155.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-26 | M | A | 6,679 | $1.75 | 1,099,133 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-26 | F | D | 2,826 | $7.76 | 1,115,983 | D | — | — | |
| 3 | Common | Common Stock | 2022-06-26 | M | A | 7,936 | $1.53 | 1,104,303 | D | — | — | |
| 4 | Common | Common Stock | 2022-06-26 | F | D | 3,116 | $7.76 | 1,101,187 | D | — | — | |
| 5 | Common | Common Stock | 2022-06-26 | M | A | 5,358 | $1.79 | 1,106,545 | D | — | — | |
| 6 | Common | Common Stock | 2022-06-26 | M | A | 5,193 | $3.00 | 1,121,176 | D | — | — | |
| 7 | Common | Common Stock | 2022-06-26 | F | D | 2,783 | $7.76 | 1,118,393 | D | — | — | |
| 8 | Common | Common Stock | 2022-06-26 | M | A | 4,917 | $3.07 | 1,123,310 | D | — | — | |
| 9 | Common | Common Stock | 2022-06-26 | F | D | 2,669 | $7.76 | 1,120,641 | D | — | — | |
| 10 | Common | Common Stock | 2022-06-26 | M | A | 5,608 | $3.29 | 1,126,249 | D | — | — | |
| 11 | Common | Common Stock | 2022-06-26 | F | D | 3,164 | $7.76 | 1,123,085 | D | — | — | |
| 12 | Common | Common Stock | 2022-06-26 | M | A | 3,239 | $4.10 | 1,126,324 | D | — | — | |
| 13 | Common | Common Stock | 2022-06-26 | F | D | 2,083 | $7.76 | 1,124,241 | D | — | — | |
| 14 | Common | Common Stock | 2022-06-26 | M | A | 3,182 | $4.50 | 1,127,423 | D | — | — | |
| 15 | Common | Common Stock | 2022-06-26 | F | D | 2,171 | $7.76 | 1,125,252 | D | — | — | |
| 16 | Common | Common Stock | 2022-06-26 | F | D | 2,239 | $7.76 | 1,104,306 | D | — | — | |
| 17 | Common | Common Stock | 2022-06-26 | M | A | 7,473 | $1.95 | 1,111,779 | D | — | — | |
| 18 | Common | Common Stock | 2022-06-26 | F | D | 3,240 | $7.76 | 1,108,539 | D | — | — | |
| 19 | Common | Common Stock | 2022-06-26 | M | A | 7,611 | $2.20 | 1,116,150 | D | — | — | |
| 20 | Common | Common Stock | 2022-06-26 | F | D | 3,485 | $7.76 | 1,112,665 | D | — | — | |
| 21 | Common | Common Stock | 2022-06-26 | M | A | 6,144 | $2.22 | 1,118,809 | D | — | — | |
| 22 | Common | Common Stock | 2022-06-26 | F | D | 2,766 | $7.76 | 1,096,367 | D | — | — | |
| 23 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 4,917 | $3.07 | 0 | D | $3.07 · — to 2024-05-12 | 4,917 Common Stock | (F8) The 4,917 options had vested in five equal annual installments commencing on 5/13/2014 the date of grant, the last tranche became fully exercisable on 5/13/2019. |
| 24 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 5,608 | $3.29 | 0 | D | $3.29 · — to 2024-09-22 | 5,608 Common Stock | (F9) The 5,608 options had vested in five equal annual installments commencing on 9/23/2014 the date of grant, the last tranche became fully exercisable on 9/23/2019. |
| 25 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 3,239 | $4.10 | 0 | D | $4.10 · — to 2024-11-10 | 3,239 Common Stock | (F10) The 3,239 options had vested in five equal annual installments commencing on 11/11/2014 the date of grant, the last tranche became fully exercisable on 11/11/2019. |
| 26 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 5,193 | $3.00 | 0 | D | $3.00 · — to 2024-02-10 | 5,193 Common Stock | (F7) The 5,193 options had vested in five equal annual installments commencing on 2/11/2014 the date of grant, the last tranche became fully exercisable on 2/11/2019. |
| 27 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 6,144 | $2.22 | 0 | D | $2.22 · — to 2023-11-21 | 6,144 Common Stock | (F6) The 6,144 options had vested in five equal annual installments commencing on 11/12/2013 the date of grant, the last tranche became fully exercisable on 11/12/2018. |
| 28 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 7,936 | $1.53 | 0 | D | $1.53 · — to 2022-11-11 | 7,936 Common Stock | (F2) The 7,936 options had vested in five equal annual installments commencing on 11/12/2012 the date of grant, the last tranche became fully exercisable on 11/12/2017. |
| 29 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 7,473 | $1.95 | 0 | D | $1.95 · — to 2023-05-12 | 7,473 Common Stock | (F4) The 7,473 options had vested in five equal annual installments commencing on 5/13/2013 the date of grant, the last tranche became fully exercisable on 5/13/2018. |
| 30 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 7,611 | $2.20 | 0 | D | $2.20 · — to 2023-09-26 | 7,611 Common Stock | (F5) The 7,611 options had vested in five equal annual installments commencing on 9/27/2013 the date of grant, the last tranche became fully exercisable on 9/27/2018. |
| 31 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 5,358 | $1.79 | 0 | D | $1.79 · — to 2023-02-10 | 5,358 Common Stock | (F3) The 5,358 options had vested in five equal annual installments commencing on 2/11/2013 the date of grant, the last tranche became fully exercisable on 2/11/2018. |
| 32 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 3,182 | $4.50 | 0 | D | $4.50 · — to 2025-02-12 | 3,182 Common Stock | (F11) The 3,182 options had vested in five equal annual installments commencing on 2/12/2015 the date of grant, the last tranche became fully exercisable on 2/12/2020. |
| 33 | Derivative | Stock Option (Right to Buy) | 2022-06-26 | M | D | 6,679 | $1.75 | 0 | D | $1.75 · — to 2022-09-24 | 6,679 Common Stock | (F1) The 6,679 options had vested in five equal annual installments commencing on 9/25/2012 the date of grant, the last tranche became fully exercisable on 9/25/2017. |